676 U.S. Pharmaceuticals & Biotech Stocks - Strong Balance Sheet Stocks - Investing Ideas

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
YMTX Yumanity Therapeutics	US$13.23	-8.3%	-41.3%	US$143.6m	n/a	PS29.7x	n/a	n/a
KDNY Chinook Therapeutics	US$40.39	0.3%	95.7%	US$2.9b	US$40.09	PS495.8x	E22.6%	n/a
EQRX EQRx	US$2.34	-5.3%	-36.2%	US$1.1b	n/a	PB1x	S123.3%	n/a
TALS Talaris Therapeutics	US$27.20	-4.9%	91.5%	US$553.2m	US$200.00	PB3.7x	n/a	n/a
GRPH Graphite Bio	US$22.26	539.7%	861.6%	US$190.4m	n/a	PB7.1x	E36.4%	n/a
NGM NGM Biopharmaceuticals	US$1.54	-3.1%	-59.8%	US$128.5m	US$1.55	PS29.1x	E14.7%	n/a
DNTH Dianthus Therapeutics	US$23.81	5.7%	n/a	US$705.5m	US$50.17	PS247.3x	E-23.3%	n/a
PCVX Vaxcyte	US$66.79	4.8%	27.6%	US$7.3b	US$103.29	PB5.9x	E-1.0%	n/a
RCUS Arcus Biosciences	US$15.26	-1.5%	-18.9%	US$1.4b	US$38.89	PS11.9x	E15.0%	n/a
PASG Passage Bio	US$1.50	11.1%	48.5%	US$97.3m	US$7.00	PB0.8x	E24.2%	n/a
QGEN Qiagen	US$42.94	0.3%	-8.5%	US$9.5b	US$50.19	PE28.3x	E12.2%	n/a
FRTX Fresh Tracks Therapeutics	US$0.94	0.4%	81.8%	US$5.4m	n/a	PB0.6x	n/a	n/a
INM InMed Pharmaceuticals	US$0.28	5.9%	-77.8%	US$1.6m	n/a	PB0.1x	S15.7%	n/a
VNDA Vanda Pharmaceuticals	US$5.36	12.4%	-20.9%	US$318.9m	US$5.21	PE124.3x	E2.4%	n/a
TRVI Trevi Therapeutics	US$2.64	-7.7%	-9.0%	US$204.3m	US$7.40	PB2.6x	E-14.0%	n/a
CORT Corcept Therapeutics	US$25.40	6.4%	5.8%	US$2.5b	US$43.60	PE22.6x	E26.4%	n/a
MGNX MacroGenics	US$14.66	-5.7%	103.3%	US$1.0b	US$24.80	PS15.6x	E-20.0%	n/a
RVMD Revolution Medicines	US$38.31	-1.3%	52.4%	US$6.6b	US$41.58	PS564x	E9.6%	n/a
SPRY ARS Pharmaceuticals	US$9.06	-2.9%	100.4%	US$917.6m	US$19.00	PS29262.1x	E56.2%	n/a
SAVA Cassava Sciences	US$21.57	-2.6%	-20.2%	US$944.1m	US$99.50	PB6.8x	E2.3%	n/a
MURA Mural Oncology	US$3.89	2.9%	n/a	US$64.8m	US$13.00	PB0.2x	n/a	n/a
VYGR Voyager Therapeutics	US$8.57	2.5%	-13.3%	US$477.0m	US$17.78	PE3.5x	E-40.3%	n/a
SGMT Sagimet Biosciences	US$4.44	8.0%	n/a	US$138.2m	US$40.00	PS70.8x	E-26.1%	n/a
AMLX Amylyx Pharmaceuticals	US$1.93	0%	-93.3%	US$134.0m	US$4.25	PE2.7x	E-18.7%	n/a

U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks